Role of Sensory Nerve Peptides Rather than Mast Cell Histamine in Paclitaxel Hypersensitivity

Yoshinori Itoh, Toshiaki Sendo, Toshio Hirakawa, Takeshi Goromaru, Shinya Takasaki, Hideaki Yahata, Hitoo Nakano, Ryozo Oishi

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Paclitaxel is one of the most extensively used anticancer agents, however, its use is often limited by severe hypersensitivity reactions, including respiratory distress, bronchospasm, and hypotension, which can occur despite premedication with dexamethasone and histamine H1 and H2 antagonists. The present study was designed to determine the mechanisms of paclitaxel hypersensitivity. In rats, paclitaxel (15 mg/kg, intravenously) caused a marked increase in pulmonary vascular permeability and edema. Pa O2 decreased, whereas PaCO2 increased, transiently after paclitaxel injection. The paclitaxel-induced pulmonary vascular hyperpermeability was blocked by dexamethasone but not by histamine H 1 or H2 antagonists. Paclitaxel increased the vascular permeability in lungs of mast cell-deficient rats Ws/Ws-/- to almost the similar extent as that elicited in wild-type rats. On the other hand, the paclitaxel-induced pulmonary vascular hyperpermeability was reversed by sensory denervation with capsaicin or pretreatment with LY303870 and SR48968, NK 1 and NK2 antagonists, respectively. Consistent with these findings, a marked elevation of sensory neuropeptides such as substance P, neurokinin A, and calcitonin gene-related peptide was observed in rat bronchoalveolar lavage fluid after paclitaxel injection. These findings suggest that sensory nerves rather than mast cells are implicated in the etiology of paclitaxel hypersensitivity.

Original languageEnglish
Pages (from-to)113-119
Number of pages7
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume169
Issue number1
Publication statusPublished - Jan 1 2004

Fingerprint

Paclitaxel
Mast Cells
Histamine
Hypersensitivity
Peptides
Lung
Capillary Permeability
1-(N-(2-methoxybenzyl)acetylamino)-3-(1H-indol-3-yl)-2-(N-(2-(4-(piperidin-1-yl)piperidin-1-yl)acetyl)amino)propane
Dexamethasone
Blood Vessels
Histamine H1 Antagonists
Histamine H2 Antagonists
Neurokinin A
Bronchial Spasm
Injections
Premedication
Calcitonin Gene-Related Peptide
Capsaicin
Bronchoalveolar Lavage Fluid
Denervation

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Itoh, Y., Sendo, T., Hirakawa, T., Goromaru, T., Takasaki, S., Yahata, H., ... Oishi, R. (2004). Role of Sensory Nerve Peptides Rather than Mast Cell Histamine in Paclitaxel Hypersensitivity. American Journal of Respiratory and Critical Care Medicine, 169(1), 113-119.

Role of Sensory Nerve Peptides Rather than Mast Cell Histamine in Paclitaxel Hypersensitivity. / Itoh, Yoshinori; Sendo, Toshiaki; Hirakawa, Toshio; Goromaru, Takeshi; Takasaki, Shinya; Yahata, Hideaki; Nakano, Hitoo; Oishi, Ryozo.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 169, No. 1, 01.01.2004, p. 113-119.

Research output: Contribution to journalArticle

Itoh, Y, Sendo, T, Hirakawa, T, Goromaru, T, Takasaki, S, Yahata, H, Nakano, H & Oishi, R 2004, 'Role of Sensory Nerve Peptides Rather than Mast Cell Histamine in Paclitaxel Hypersensitivity', American Journal of Respiratory and Critical Care Medicine, vol. 169, no. 1, pp. 113-119.
Itoh, Yoshinori ; Sendo, Toshiaki ; Hirakawa, Toshio ; Goromaru, Takeshi ; Takasaki, Shinya ; Yahata, Hideaki ; Nakano, Hitoo ; Oishi, Ryozo. / Role of Sensory Nerve Peptides Rather than Mast Cell Histamine in Paclitaxel Hypersensitivity. In: American Journal of Respiratory and Critical Care Medicine. 2004 ; Vol. 169, No. 1. pp. 113-119.
@article{5d1925ac84a349b9aff5ec44f93fad84,
title = "Role of Sensory Nerve Peptides Rather than Mast Cell Histamine in Paclitaxel Hypersensitivity",
abstract = "Paclitaxel is one of the most extensively used anticancer agents, however, its use is often limited by severe hypersensitivity reactions, including respiratory distress, bronchospasm, and hypotension, which can occur despite premedication with dexamethasone and histamine H1 and H2 antagonists. The present study was designed to determine the mechanisms of paclitaxel hypersensitivity. In rats, paclitaxel (15 mg/kg, intravenously) caused a marked increase in pulmonary vascular permeability and edema. Pa O2 decreased, whereas PaCO2 increased, transiently after paclitaxel injection. The paclitaxel-induced pulmonary vascular hyperpermeability was blocked by dexamethasone but not by histamine H 1 or H2 antagonists. Paclitaxel increased the vascular permeability in lungs of mast cell-deficient rats Ws/Ws-/- to almost the similar extent as that elicited in wild-type rats. On the other hand, the paclitaxel-induced pulmonary vascular hyperpermeability was reversed by sensory denervation with capsaicin or pretreatment with LY303870 and SR48968, NK 1 and NK2 antagonists, respectively. Consistent with these findings, a marked elevation of sensory neuropeptides such as substance P, neurokinin A, and calcitonin gene-related peptide was observed in rat bronchoalveolar lavage fluid after paclitaxel injection. These findings suggest that sensory nerves rather than mast cells are implicated in the etiology of paclitaxel hypersensitivity.",
author = "Yoshinori Itoh and Toshiaki Sendo and Toshio Hirakawa and Takeshi Goromaru and Shinya Takasaki and Hideaki Yahata and Hitoo Nakano and Ryozo Oishi",
year = "2004",
month = "1",
day = "1",
language = "English",
volume = "169",
pages = "113--119",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "1",

}

TY - JOUR

T1 - Role of Sensory Nerve Peptides Rather than Mast Cell Histamine in Paclitaxel Hypersensitivity

AU - Itoh, Yoshinori

AU - Sendo, Toshiaki

AU - Hirakawa, Toshio

AU - Goromaru, Takeshi

AU - Takasaki, Shinya

AU - Yahata, Hideaki

AU - Nakano, Hitoo

AU - Oishi, Ryozo

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Paclitaxel is one of the most extensively used anticancer agents, however, its use is often limited by severe hypersensitivity reactions, including respiratory distress, bronchospasm, and hypotension, which can occur despite premedication with dexamethasone and histamine H1 and H2 antagonists. The present study was designed to determine the mechanisms of paclitaxel hypersensitivity. In rats, paclitaxel (15 mg/kg, intravenously) caused a marked increase in pulmonary vascular permeability and edema. Pa O2 decreased, whereas PaCO2 increased, transiently after paclitaxel injection. The paclitaxel-induced pulmonary vascular hyperpermeability was blocked by dexamethasone but not by histamine H 1 or H2 antagonists. Paclitaxel increased the vascular permeability in lungs of mast cell-deficient rats Ws/Ws-/- to almost the similar extent as that elicited in wild-type rats. On the other hand, the paclitaxel-induced pulmonary vascular hyperpermeability was reversed by sensory denervation with capsaicin or pretreatment with LY303870 and SR48968, NK 1 and NK2 antagonists, respectively. Consistent with these findings, a marked elevation of sensory neuropeptides such as substance P, neurokinin A, and calcitonin gene-related peptide was observed in rat bronchoalveolar lavage fluid after paclitaxel injection. These findings suggest that sensory nerves rather than mast cells are implicated in the etiology of paclitaxel hypersensitivity.

AB - Paclitaxel is one of the most extensively used anticancer agents, however, its use is often limited by severe hypersensitivity reactions, including respiratory distress, bronchospasm, and hypotension, which can occur despite premedication with dexamethasone and histamine H1 and H2 antagonists. The present study was designed to determine the mechanisms of paclitaxel hypersensitivity. In rats, paclitaxel (15 mg/kg, intravenously) caused a marked increase in pulmonary vascular permeability and edema. Pa O2 decreased, whereas PaCO2 increased, transiently after paclitaxel injection. The paclitaxel-induced pulmonary vascular hyperpermeability was blocked by dexamethasone but not by histamine H 1 or H2 antagonists. Paclitaxel increased the vascular permeability in lungs of mast cell-deficient rats Ws/Ws-/- to almost the similar extent as that elicited in wild-type rats. On the other hand, the paclitaxel-induced pulmonary vascular hyperpermeability was reversed by sensory denervation with capsaicin or pretreatment with LY303870 and SR48968, NK 1 and NK2 antagonists, respectively. Consistent with these findings, a marked elevation of sensory neuropeptides such as substance P, neurokinin A, and calcitonin gene-related peptide was observed in rat bronchoalveolar lavage fluid after paclitaxel injection. These findings suggest that sensory nerves rather than mast cells are implicated in the etiology of paclitaxel hypersensitivity.

UR - http://www.scopus.com/inward/record.url?scp=1242320973&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1242320973&partnerID=8YFLogxK

M3 - Article

VL - 169

SP - 113

EP - 119

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 1

ER -